- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Mammographers receivewarnings on lidocaine risks
The FDA has issued an advisory warning to physicians and patients about potential health risks from topical anesthetic lidocaine used to reduce the discomfort of breast compression during mammography.
The FDA has issued an advisory warning to physicians and patients about potential health risks from topical anesthetic lidocaine used to reduce the discomfort of breast compression during mammography.
Dr. Colleen K. Lambertz and colleagues at St. Luke's Mountain States Tumor Institute in Boise, ID, discussed the potential value of nonprescription lidocaine gel spread before mammography in the September 2008 issue of Radiology (248[3]:765-771). Lambertz reported that lidocaine produced a few minor side effects, but the FDA noted in January that the study was not large enough to evaluate the potential for serious reactions. The deaths of two women who used topical anesthetics prior to laser hair removal led the FDA to issue in early 2007 an advisory on potentially lifethreatening side effects of skin products containing numbing ingredients and guidelines for safer use.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
